Lifeward appoints interim CEO and CFO amid growth momentum
Aug 31, 2026, 4:23 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Positive momentum from quarterly results and scalable growth plan; leadership changes often cause near-term sentiment shifts, but the combination of revenue growth and a seasoned interim CEO/CFO increases the probability of sustained execution.
AI summary
What happened, with direct paths to the underlying reporting
Lifeward named Josh Hexter as interim CEO and Rami Aviram as CFO, effective Sept 1 and Nov 1, 2026. The leadership transition aligns with a growing rehab-focused growth plan, supported by Q2 revenue of $6.6 million, with ReWalk exoskeleton sales up 13% and AlterG revenue up 25%. If execution accelerates under the new team, Lifeward could extend its revenue trajectory and expansion into POD platforms.
Lifeward names Josh Hexter Interim CEO; Rami Aviram CFO effective Sept 1 and Nov 1, 2026.
Outgoing CEO Mark Grant to consult through Sept 30, 2026.
Q2 2026 revenue up 16% YoY to $6.6M; ReWalk +13%, AlterG +25%.
Strategy targets scaling rehab via reimbursement and distribution; POD ORMD-0801 expansion.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Summary: - ReWalk Robotics had a quarterly loss of $0.73 per share, missing estimates and posting a revenue of $5.28 million. - The company has exceeded EPS estimates three times…